close

Mergers and Acquisitions

1 2 3 4 5 31
Number of results: 617
Date Acquired company Acquiring company Amount Related
2017-05-16 HansaBioMed Life Sciences (Estonia) Lonza (Switzerland) undisclosed Technology - Services
2017-05-09 iLab, Biosphere and two specialty clinical testing laboratories (France) Eurofins Scientific (Luxembourg) diagnostic
2017-05-04 MVZ für Laboratoriumsmedizin am Hygiene-Institut GmbH (Hygel) (Germany) Eurofins Scientific (Luxembourg) diagnostic
2017-05-04 Hygel (Germany) Eurofins Scientific (Luxembourg) undisclosed Technology - Services
2017-05-03 MiNA Therapeutics (UK) Sosei (Japan) £ 175 million Cancer - Oncology
2017-04-11 Asymptote (UK) GE Healthcare (USA - WI) undisclosed Technology - Services
2017-04-03 assets and relevant business related to the CELLSEARCH® Circulating Tumor Cell System from Janssen Diagnostics (USA - PA) Menarini-Silicon Biosystems, a Menarini group company (Italy) undisclosed Cancer - Oncology - Diagnostic
2017-03-30 Symetis (Switzerland) Boston Scientific (USA - MA) $435 million Medical devices Cardiovascular diseases
2017-03-23 Agalimmune (UK) Bioline Rx (Israel) $6 million and additional future payments based on development and commercial milestones Cancer - Oncology
2017-03-23 Euchloe Bio (Singapore) Tessa Therapeutics (Singapore) undisclosed Cancer - Oncology
2017-03-20 Mallinckrodt's intrathecal therapy business (UK) Piramal (India) $203 million
2017-03-17 Threshold Pharmaceuticals (USA - CA) Molecular Templates (USA - TX) Cancer - Oncology
2017-03-16 PCT, a Caladrius Company (USA - CA) Hitachi Chemical Co. America (USA - CA) $75 million in cash and $5 million revenue-based milestone Technology - Services Production - Manufacturing
2017-03-01 CoLucid Pharmaceuticals (USA - IN) Eli Lilly (USA - IN) $960 million CNS diseases - Neurological diseases
2017-02-28 Genticel (France) Genkyotex (Switzerland) € 30 million Cancer-Oncology Infectious diseases
2017-02-16 Ariad Pharmaceuticals (USA - MA) Takeda Pharmaceutical (Japan) $5.2 billion

Cancer - Oncology

2017-02-13 Zeltiq Aesthetics (USA - CA) Allergan (Ireland) $2.475 billion

Aesthetic medicine

2017-02-13 Signal Therapeutics (USA - IIO) Miragen Therapeutics (USA - CA)
2017-01-31 Akkadeas Pharma (Italy) Ipsen (France) Gastrointestinal diseases
2017-01-27 Mallinckrodt's nuclear imaging business (UK) IBA Molecular (Belgium) $690 million